×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Merck's BCG monopoly could end
Fierce Pharma
ImmunityBio last week won the FDA's approval for its immunotherapy Anktiva to be used alongside the Bacillus Calmette-Guérin (BCG) vaccine...
7 hours ago
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Yahoo Finance
After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE: MRK) just reported encouraging...
1 day ago
Cerevance receives milestone payment under Alzheimer's collaboration with Merck
Seeking Alpha
Privately held Cerevance has received a milestone payment worth an undisclosed amount related to its partnership with Merck (NYSE:MRK) to...
1 day ago
Merck reports data from Phase III gastric cancer treatment trial
Clinical Trials Arena
Merck has announced the final analysis findings from the Phase III trial of KEYTRUDA regimen to treat gastric adenocarcinoma.
1 day ago
Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line ...
Yahoo Finance
RAHWAY, N.J., May 01, 2024--Merck Announces KEYNOTE-811 Trial Met Dual Primary Endpoint as First-Line Treatment in Patients With...
2 days ago
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC
Merck reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug...
1 week ago
Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Reuters
Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug...
1 week ago
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The New York Times
The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver this year.
2 weeks ago
Stocks making biggest moves premarket: Meta, Merck, Southwest and more
CNBC
Unlock this article by creating a free CNBC account. Benefits include creating stock watchlists and more. Already have a CNBC account?
1 week ago
Here's Why Merck (MRK) is a Strong Momentum Stock
Yahoo Finance Canada
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the...
8 hours ago